Biopac India Corporation Ltd. announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2013. For the third quarter, the company reported net sales/income from operations of INR 129.741 million against INR 129.132 million a year ago. Total income from operations (net) was INR 129.741 million against INR 129.132 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 8.535 million against INR 6.442 million a year ago. Profit from ordinary activities before tax was INR 3.164 million against INR 4.208 million a year ago. Net profit from ordinary activities after tax was INR 2.201 million or INR 0.13 per basic and diluted share before and after extraordinary items against INR 3.329 million or INR 0.19 per basic and diluted share before and after extraordinary items a year ago.

For the nine months, the company reported net sales/income from operations of INR 378.733 million against INR 318.867 million a year ago. Total income from operations (net) was INR 378.733 million against INR 318.857 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 20.583 million against INR 12.346 million a year ago. Profit from ordinary activities before tax was INR 6.843 million against INR 8.382 million a year ago. Net profit from ordinary activities after tax was INR 7.054 million or INR 0.41 per basic and diluted share before and after extraordinary items against INR 5.938 million or INR 0.34 per basic and diluted share before and after extraordinary items a year ago.